SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-023794
Filing Date
2024-09-20
Accepted
2024-09-20 17:47:35
Documents
1
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 form4-09202024_090932.html 4  
1 form4-09202024_090932.xml 4 6191
  Complete submission text file 0001415889-24-023794.txt   7741
Mailing Address C/O ESPERION THERAPEUTICS INC. 3891 RANCHERO DRIVE SUITE 150 ANN ARBOR MI 48108
Business Address
Hall Ashley (Reporting) CIK: 0001801842 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41608 | Film No.: 241314279

Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

IRS No.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)